These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 21751403

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis, evaluation and absolute configuration assignment of novel dihydropyrimidin-2-ones as picomolar sodium iodide symporter inhibitors.
    Lacotte P, Buisson DA, Ambroise Y.
    Eur J Med Chem; 2013 Apr; 62():722-7. PubMed ID: 23454514
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and evaluation of 3,4-dihydropyrimidin-2(1H)-ones as sodium iodide symporter inhibitors.
    Lacotte P, Puente C, Ambroise Y.
    ChemMedChem; 2013 Jan; 8(1):104-11. PubMed ID: 23132843
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A nonradioactive iodide uptake assay for sodium iodide symporter function.
    Waltz F, Pillette L, Ambroise Y.
    Anal Biochem; 2010 Jan 01; 396(1):91-5. PubMed ID: 19733144
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT, Yuan TT, Liu HH, Chen SF, Wu YT.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6373-7. PubMed ID: 17889528
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and evaluation of imidazo[2,1-b]thiazoles as iodide efflux inhibitors in thyrocytes.
    Lecat-Guillet N, Ambroise Y.
    ChemMedChem; 2009 Nov 15; 4(11):1819-30. PubMed ID: 19780099
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators.
    Lum RT, Cheng M, Cristobal CP, Goldfine ID, Evans JL, Keck JG, Macsata RW, Manchem VP, Matsumoto Y, Park SJ, Rao SS, Robinson L, Shi S, Spevak WR, Schow SR.
    J Med Chem; 2008 Oct 09; 51(19):6173-87. PubMed ID: 18788731
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships.
    Camacho ME, León J, Entrena A, Velasco G, Carrión MD, Escames G, Vivó A, Acuña-Castroviejo D, Gallo MA, Espinosa A.
    J Med Chem; 2004 Nov 04; 47(23):5641-50. PubMed ID: 15509163
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. de novo design and synthesis of N-benzylanilines as new candidates for VEGFR tyrosine kinase inhibitors.
    Uno M, Ban HS, Nabeyama W, Nakamura H.
    Org Biomol Chem; 2008 Mar 21; 6(6):979-81. PubMed ID: 18327319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.